Company Summary
KDH THONBURI MEDICAL CENTRE PUBLIC COMPANY LIMITED
Services/Health Care Services
SET
CG Report:   -
 
  Data as of 18 Jan 2022  
Price (B.) 52 Week High/Low P/E (X) P/BV (X) Paid-up (MB.) Market Cap (MB.) EV (MB.) EBITDA (MB.) EV/EBITDA
83.75 100.00 / 80.00 51.93 3.29 193.84 1,623.43 1,562.21 90.51 13.32
News
Date/Time Subject
09 Nov 2021 08:41   Financial Performance Quarter 3 (F45) (Reviewed) (Revised )
08 Nov 2021 17:40   Financial Performance Quarter 3 (F45) (Reviewed)
08 Nov 2021 17:36   Financial Statement Quarter 3/2021 (Reviewed)
08 Nov 2021 17:36   Management Discussion and Analysis Quarter 3 Ending 30 Sep 2021
25 Oct 2021 08:23   Appointment of Director, Independent Director and Audit Committee Member
more

Company Profile
Address 337 TAKSIN ROAD, SUMLHAE, THON BURI Bangkok 10600
Telephone 0-2438-0040-5
Fax 0-2438-5642
URL www.samitivejthonburi.com
Establish Date 29/12/1977 Listed Date 17/10/1989
IPO Price (Baht) N/A
IPO Financial Advisory N/A
Par 10.00 Baht
Last Par Change N/A

Business
Thonburi Medical Centre Public Company Limited engages in the healthcare services business under Samitivej Thonburi Hospital, formerly known as Krungthon 1 Hospital. The hospital provides 24-hour medical services to patients with a team of specialized doctors, and is fully equipped with all modern technology facilities as necessary to provide medical diagnostic and treatment of all kinds. The hospital provides all kinds of treatments to its patients with specialized centers and units such as Samitivej Breast Institute, Muscle, Bone and Joint Center, Advanced Eye and LASIK Center, Gastroenterology and Intestine Center, Wellness Center, and Emergency Department etc.

Free Float 05 Mar 2021 07 Jul 2020
% /Shareholders
35.94% 985 35.94% 1,001
Foreign Shareholders 0.30% (As of 18/01/2022) Foreign Limit 30.00%
NVDR Shareholders  0.02% (As of 18/01/2022)
5 Yr Price Performance (Adjusted Price)
Price Performance (Adjusted Price) Compare to Stock (%) Compare to Sector (%) Compare to Market (%)
5 Days -0.89 0.95 -0.48
20 Days 2.13 4.58 0.99
60 Days -2.62 -1.66 -3.58
120 Days 0.90 2.31 -4.32
YTD 0.90 4.27 0.74
P/E (X) 51.93 29.97 20.85
P/BV (X) 3.29 4.14 1.79
Turnover Ratio (%) 0.02 0.24 2.07

Top 10 Major Shareholders(@05 Mar 2021) Share %
1. บริษัท กรุงเทพดุสิตเวชการ จำกัด (มหาชน) 6,787,043 35.01
2. บริษัท รอยัลบางกอก เฮ็ลธ์แคร์ จำกัด 5,626,288 29.03
3. MRS. VALLY SUNGSIRI 968,900 5.00
4. นาย KHANPETCH SARASAS 400,100 2.06
5. MR. KRASIAN TANTIPHALACHEVA 343,700 1.77
6. นาย PUN SARASAS 262,900 1.36
7. นาย เทพทัย จิรบวรวิสุทธิ์ 242,052 1.25
8. นาง ดวงสุดา นิมมลรัตน์ 171,000 0.88
9. นาย ทวี สมบัติกุลธนะ 163,500 0.84
10. นาง ดวงแก้ว ตระกูลพิพัฒน์ 142,500 0.74

Management Position
1. Mr. CHAIRAT PANTHURAAMPHORN CHAIRMAN
2. M.D. NIVAT JEEGUNGWAL MANAGING DIRECTOR / DIRECTOR
3. Mr. PRADIT THEEKAKUL DIRECTOR
4. Mr. KITTISAK BENCHARIT INDEPENDENT DIRECTOR / AUDIT COMMITTEE
5. Pol.Maj. CHUMSAK PRUKSAPONG INDEPENDENT DIRECTOR / CHAIRMAN OF THE AUDIT COMMITTEE
6. Mr. JUMPHOT CHUASAI INDEPENDENT DIRECTOR / AUDIT COMMITTEE
Accumulated: Turnover Ratio, Value Trade/Day
Statistics YTD
18 Jan 2022
2021
30 Dec 2021
2020
30 Dec 2020
Listed share (M.) 19.38  19.38  19.38 
Market Cap (MB.) 1,623.43  1,608.89  1,647.66 
Price (B./share) 83.75  83.00  85.00 
BVPS (B./Share) 25.49  25.49  23.88 
P/BV (X) 3.29  3.26  3.56 
P/E (X) 51.93  51.47  N/A 
Turnover Ratio (%) 0.04  0.74  2.07 
Value Trade/Day (MB.) 0.06  0.05  0.14 
Beta 0.01  -0.01  0.53 
 
Rate of Return YTD  2021  2020 
Price Change (%) 0.90  -2.35  -6.59 
Dividend Yield (%) N/A  N/A  N/A 
Payout Ratio N/A 
Dividend Policy Not less than 70% of the annual operating net profit

Dividend
Operation Period Dividend/Share Unit Payment Date Type
No Information Found
 
Auditor
(Effective Until 31/12/2021)
MS. KAMONTIP LERTWITWORATEP/EY OFFICE LIMITED
MR. WICHART LOKATEKRAWEE/EY OFFICE LIMITED
Mr. SAMRAN TAENGCHAM/EY OFFICE LIMITED
F/S Year ended 31/12
Latest Type of Report Unqualified opinion with an emphasis of matters
Financial Data
Statement of Financial Position (MB.) 9M/2021 
(01/01/21 
-30/09/21) 
9M/2020 
(01/01/20 
-30/09/20) 
2020 
(01/01/20 
-31/12/20) 
2019 
(01/01/19 
-31/12/19) 
2018 
(01/01/18 
-31/12/18) 
Accounting Type Company Company Company Company Company
Cash And Cash Equivalents 192.74 147.91 156.26 127.24 90.56
A/R Net 72.51 56.53 68.15 68.87 83.38
Inventories 7.77 5.39 7.73 6.43 5.24
Current Assets 338.21 209.83 232.13 202.54 179.18
PP&E Net 261.67 326.87 314.40 374.75 401.45
Non-Current Assets 287.42 372.20 350.27 420.66 449.09
Total Assets 625.63 582.03 582.40 623.20 628.27
OD - - - - 50.00
A/P Net 42.63 45.46 45.87 58.17 45.38
Current portion of LT - - - - -
Current Liabilities 103.92 93.74 90.33 121.52 156.23
Non-Current Liabilities 27.60 25.44 24.65 23.77 16.28
Total Liabilities 131.52 119.18 114.98 145.28 172.51
Authorized Capital 225.00 225.00 225.00 225.00 225.00
Paid-Up Capital 193.84 193.84 193.84 193.84 193.84
Premium (Discount) on Share Capital 372.58 372.58 372.58 372.58 372.58
Retained Earnings (Deficit) -72.31 -103.57 -99.00 -88.51 -110.66
Treasury Stock - - - - -
Shares Of The Company Held By Subsidiaries - - - - -
Other Components Of Equity - - - - -
 - Surplus (Deficits) - - - - -
Shareholders' Equity 494.11 462.85 467.42 477.91 455.76
Minority Interest - - - - -
more
Statement of Comprehensive Income (MB.) 9M/2021 
(01/01/21 
-30/09/21) 
9M/2020 
(01/01/20 
-30/09/20) 
2020 
(01/01/20 
-31/12/20) 
2019 
(01/01/19 
-31/12/19) 
2018 
(01/01/18 
-31/12/18) 
Accounting Type Company Company Company Company Company
Revenue From Operations 547.26 511.66 688.36 945.50 766.59
Other Income 6.73 7.40 9.83 13.80 10.70
Total Revenues 554.20 519.23 698.44 959.30 777.29
Costs 397.77 388.11 522.22 662.39 547.15
Selling And Administrative Expenses 121.76 141.87 179.27 268.09 216.90
Total Cost And Expenses 519.53 529.98 701.49 930.48 764.05
EBITDA 90.51 46.57 73.32 101.82 87.12
Depre. & Amor. 55.84 57.32 76.36 73.00 73.88
EBIT 34.67 -10.75 -3.04 28.82 13.23
Net Profit : Owners Of The Parent 26.69 -13.56 -8.99 24.81 31.11
EPS (B.) 1.38 -0.70 -0.46 1.28 1.60
more
Statement of Cash Flow (MB.) 9M/2021 
(01/01/21 
-30/09/21) 
9M/2020 
(01/01/20 
-30/09/20) 
2020 
(01/01/20 
-31/12/20) 
2019 
(01/01/19 
-31/12/19) 
2018 
(01/01/18 
-31/12/18) 
Accounting Type Company Company Company Company Company
Operating Cash Flow 97.56 30.99 41.59 134.83 54.55
Investing Cash Flow -60.78 -10.18 -12.38 -46.27 -24.23
Financing Cash Flow -0.29 -0.14 -0.19 -51.89 -8.85
Net Cash Flow 36.49 20.68 29.02 36.68 21.47
more
Annualized: ROE, ROA
Ratios 9M/2021  9M/2020  2020  2019 
Current Ratio (X) 3.25 2.24 2.57 1.67
ROE (%) 6.53 -2.62 -1.90 5.31
ROA (%) 7.02 -2.06 -0.50 4.61
D/E (X) 0.27 0.26 0.25 0.30
Total Asset Turnover (X) 1.21 1.29 1.16 1.53
Gross Profit Margin (%) 27.32 24.15 24.14 29.94
EBIT Margin (%) 6.26 -2.07 -0.44 3.00
Net Profit Margin (%) 4.82 -2.61 -1.29 2.59

Information only PP, PO, XR and XD
Capital Movement (Last 3 Year)
Date CA Type Changed paid up share Paid up share Par
No Information Found

Growth Rate (%) 9M/2021  9M/2020  2020  2019 
Sales Growth 6.96 -25.68 -27.20 23.34
COGs Growth 2.49 -18.95 -21.16 21.06
Total Revenue Growth 6.73 -25.60 -27.19 23.42
Total Expense Growth -1.97 -20.58 -24.61 21.78
Net Profit Growth N/A N/A N/A -20.27

Annualized
Cash Cycle 9M/2021  9M/2020  2020  2019 
A/R Turnover (Times) 11.22 11.23 10.05 12.42
Avg. Collection Period (Days) 32.53 32.49 36.33 29.39
Inventory Turnover (Times) 80.83 109.12 73.78 113.53
Avg. Inventory Period (Days) 4.52 3.35 4.95 3.21
A/P Turnover (Times) 12.08 11.46 10.04 12.79
Avg. Payment Period (Days) 30.23 31.85 36.36 28.53
Cash Cycle (Days) 6.82 3.98 4.91 4.07


Trading Sign (Latest)
Trading Alert Posted Date Lifted Date
No Information Found

Market Alert (Latest)
No Information Found
more

Only Preferred Share and Warrants
Other Securities
Securities Name -

Remark - Calculated from adjusted price
  - Presented and calculated from the consolidated statement and displayed as cumulative quarterly statement by fiscal year (Company statement will be presented and calculated incase consolidated statement is not available.)
  - The information is quarterly updated within 7 business days after the new financial statement is submitted.
  -
 
Information on the financial statements is presented according to the information that the listed companies submit on that period. The investors should study additional information from the companies' financial statements since some companies may restate the comparing financial statements on the latest financial statements.
Source: www.set.or.th (Copyright © The Stock Exchange of Thailand)
The materials and information on this site are provided for informative and educational purpose only, and do not constitute or form a part of any advice or recommendation regarding any securities. The Stock Exchange of Thailand has no responsibility for the accuracy, suitability and completeness of any information, materials, statements, figures, reports or opinions provided, and has no responsibility for any losses and damages in any cases. In case you have any inquiries or clarification regarding this summary, please directly contact the listed company who made this summary.